Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population

BACKGROUND: The association of recombinant FSH (rFSH) plus recombinant LH (rLH) is currently used for Controlled Ovarian Stimulation (COS) in human IVF, but its efficacy has, to date, not yet been compared to that of human Menopausal Gonadotropin (hMG), the FSH + LH activity-containing urinary drug....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Reprod Biol Endocrinol
Main Authors: Revelli, Alberto, Pettinau, Grazia, Basso, Gemma, Carosso, Andrea, Ferrero, Alessandro, Dallan, Cecilia, Canosa, Stefano, Gennarelli, Gianluca, Guidetti, Daniela, Filippini, Claudia, Benedetto, Chiara
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4514947/
https://ncbi.nlm.nih.gov/pubmed/26209525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12958-015-0080-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados